Maureen D. Mayes

1995–2025 年に発表

145
論文数
30,615
被引用数
90
h 指数
139
i10 指数

被引用数

Maureen D. Mayes の年別被引用数1982 年: 被引用 4 件1985 年: 被引用 3 件1996 年: 被引用 8 件1997 年: 被引用 13 件1998 年: 被引用 13 件1999 年: 被引用 20 件2000 年: 被引用 25 件2001 年: 被引用 36 件2002 年: 被引用 31 件2003 年: 被引用 69 件2004 年: 被引用 59 件2005 年: 被引用 68 件2006 年: 被引用 90 件2007 年: 被引用 145 件2008 年: 被引用 144 件2009 年: 被引用 182 件2010 年: 被引用 209 件2011 年: 被引用 198 件2012 年: 被引用 223 件2013 年: 被引用 175 件2014 年: 被引用 197 件2015 年: 被引用 237 件2016 年: 被引用 244 件2017 年: 被引用 256 件2018 年: 被引用 220 件2019 年: 被引用 1,056 件2020 年: 被引用 1,100 件2021 年: 被引用 980 件2022 年: 被引用 819 件2023 年: 被引用 595 件2024 年: 被引用 842 件2025 年: 被引用 355 件2026 年: 被引用 5 件1983〜1984 年は被引用が無いため表示していません1986〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,199 件、この内訳の 23.1%イギリス: 引用元論文 830 件、この内訳の 8.7%イタリア: 引用元論文 735 件、この内訳の 7.7%フランス: 引用元論文 554 件、この内訳の 5.8%ドイツ: 引用元論文 544 件、この内訳の 5.7%中国: 引用元論文 510 件、この内訳の 5.3%カナダ: 引用元論文 416 件、この内訳の 4.4%オランダ: 引用元論文 329 件、この内訳の 3.5%日本: 引用元論文 325 件、この内訳の 3.4%スイス: 引用元論文 321 件、この内訳の 3.4%スペイン: 引用元論文 257 件、この内訳の 2.7%オーストラリア: 引用元論文 240 件、この内訳の 2.5%
0%23.1%その他 23.8%

分野

  • Medicine84.4%
  • Biochemistry, Genetics and Molecular Biology7%
  • Immunology and Microbiology3.9%
  • Neuroscience2.2%
  • Engineering0.4%
  • Psychology0.3%
  • その他1.8%

トピック

  • Systemic Sclerosis and Related Diseases17.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.7%
  • Inflammatory Myopathies and Dermatomyositis6.1%
  • Systemic Lupus Erythematosus Research3.2%
  • Rheumatoid Arthritis Research and Therapies2.7%
  • Multiple Sclerosis Research Studies2.7%
  • その他59.1%

共著者

全論文

検索で開く
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 被引用: 3,406

  2. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 1,613

  3. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 被引用: 1,062

  4. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark L. Metersky - New England Journal of Medicine 2006 被引用: 1,667

  5. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst - New England Journal of Medicine 2018 被引用: 589

  6. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , - Journal of Scleroderma and Related Disorders 2017 被引用: 521

  7. Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leo A. B. Joosten, Vanessa Smith, Filip De Keyser, Rafaella Scorza, C. Lunardi, Piet L. C. M. van Riel, Madelon C Vonk, Waander L. van Heerde, Stephan Meller, Bernhard Homey, Lorenzo Beretta, Mark Roest, Maria Trojanowska, Robert Lafyatis, Timothy R. D. J. Radstake - New England Journal of Medicine 2013 被引用: 454

  8. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

    著者: , , , , , , , , , , , , , - Arthritis & Rheumatism 2007 被引用: 2,077

  9. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 被引用: 212

  10. Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 178

  11. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Respiratory Research 2023 被引用: 142

  12. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hugh S. Markus, James T. Elder, Jo Knight, Dan E. Arking, Timothy D. Spector, Bobby P. C. Koeleman, Cornelia M. van Duijn, Javier Martı́n, Andrew P. Morris, Rinse K. Weersma, Cisca Wijmenga, Patricia B. Munroe, John R. B. Perry, Jennie G. Pouget, Yalda Jamshidi, Harold Snieder, Behrooz Z. Alizadeh - PLoS Medicine 2016 被引用: 206

  13. Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yue Wang, Tammara Wood, Yannick Allanore, M. Matucci-Cerinic, Oliver Distler, Ora Singer, Erica Bush, David A. Fox, Daniel E. Furst - Arthritis & Rheumatology 2019 被引用: 224

  14. Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

    著者: , , , , , , , , , , - Arthritis Care & Research 2009 被引用: 247

  15. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher P. Denton, the RESOLVE‐1 Study Group - Arthritis & Rheumatology 2023 被引用: 43

  16. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

    著者: , , , , , , - Arthritis & Rheumatism 2003 被引用: 930

  17. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis

    著者: , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 108

  18. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 被引用: 498

  19. Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192

    著者: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2006 被引用: 451

  20. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meng May Chee, Rajan Madhok, Paul G. Shiels, René Westhovens, Alexander Kreuter, Hans P. Kiener, Elfride de Baere, Torsten Witte, Leonid Padykov, Lars Klareskog, Lorenzo Beretta, Rafaella Scorza, Benedicte A. Lie, Anna‐Maria Hoffmann‐Vold, Patrícia Carreira, John Varga, Monique Hinchcliff, Peter K. Gregersen, Annette T. Lee, Binwu Ying, Younghun Han, Shih‐Feng Weng, Christopher I. Amos, Fredrick M. Wigley, Laura K. Hummers, J. Lee Nelson, Sandeep K. Agarwal, Shervin Assassi, Pravitt Gourh, Filemon K. Tan, Bobby P. C. Koeleman, Frank C. Arnett, Javier Martı́n, Maureen D. Mayes - Nature Genetics 2010 被引用: 403

  21. Systemic sclerosis and lupus: Points in an interferon‐mediated continuum

    著者: , , , , , , , , , , , , , - Arthritis & Rheumatism 2010 被引用: 208

  22. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2016 被引用: 156

  23. Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2020 被引用: 104

  24. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

    著者: , , , , , , , , , , - Arthritis Research & Therapy 2016 被引用: 86